This little-known ASX cannabis share has quietly gained 26% in a month to trade at all-time highs

Why is this ASX cannabis share having such a stellar month?

| More on:
A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • This ASX cannabis share has ascended 26% in a month   
  • In the year to date, the share price has exploded 65% 
  • On Friday alone, the company's shares soared 8.57%

The S&P/ASX 200 Index (ASX: XJO) may be down in the past month but this ASX cannabis share has steamed ahead.

The Cronos Australia Ltd (ASX: CAU) share price has rocketed 26.67% over the past 30 days. On Friday alone, the company's shares leapt by 8.57% to finish the session at 38 cents. Earlier in the day, they hit an all-time high of 39.5 cents.

Let's take a look at what could be helping this ASX cannabis share grow.

Why is this ASX cannabis share doing so well?

Cronos Australia is a medicinal cannabis company operating in the medical, clinics, and consumer segments.

Cronos merged with CDA Health Pty Ltd in December. The board appointed four new directors, Guy Headley, Benjamin Jansen, Kurt Schmidt, and Marcia Walker. CDA Health is now a wholly-owned subsidiary of Cronos Australia.

On 27 January, Cronos reported its medicinal cannabis unit sales in H1 FY2022 exceeded total sales for all of FY2021.

The Cronos Australia CEO, Rodney Cocks, described the merger with CDA Health as a "game changer" for the cannabis company and its shareholders.

Cocks said:

The merger with CDA Health is a key milestone achieved by Cronos Australia since its IPO in late 2019 and should propel the integrated company to a position of market leadership in Australia and position it for sustainable, profitable growth.

The combined Cronos Australia and CDA Health business will allow us to take the Company to the next level of growth, both in Australia and offshore.

Cronos Group Inc (TSE: CRON, NASDAQ: CRON) is the largest shareholder of Cronos Australia with a 31% stake.

Cronos share price snapshot

This little-known ASX cannabis share has ascended in value by 153% over the past year and 65% this year to date. For perspective, the benchmark ASX 200 index has returned 6% over the past year.

Cronos has a market capitalisation of about $209 million based on the current share price.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Cannabis Shares

Man in the green house growing medical cannabis
Cannabis Shares

ASX cannabis stocks eyeing $1 billion domestic market

Legal cannabis use is soaring in Australia.

Read more »

two men in formal business clothing closely inspect a bud from a cannabis crop.
Cannabis Shares

2 ASX cannabis shares with big news today

What's going on with these pot stocks today? Let's find out.

Read more »

A man in a horse head mask and suit jumps for joy on a beach.
Cannabis Shares

Could ASX cannabis shares be set for a smoking hot rebound?

ASX cannabis stocks could be set for a strong finish to 2024.

Read more »

Man in a cannabis greenhouse looks unhappy and puts his thumb down.
Cannabis Shares

Why are these 2 ASX cannabis stocks sputtering today?

Up 174% in 2023, this ASX cannabis share is giving back some more of its gains today.

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Cannabis Shares

Guess which ASX cannabis share is crashing 36% following an FDA blow

Rookie mistake: This cannabis share just missed out on FDA approval for a simple reason.

Read more »

A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
Cannabis Shares

Could ASX cannabis shares be set for a resurgence?

The world's legal and medical fraternities are taking small steps forward in the medicinal cannabis movement.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Cannabis Shares

This ASX cannabis stock is up 160% since June, and it has an FDA ruling coming up!

Investors are very excited about this cannabis stock.

Read more »

two men in formal business clothing closely inspect a bud from a cannabis crop.
Cannabis Shares

Why ASX cannabis shares just jumped back into the spotlight

ASX cannabis shares operate in a nation where medical marijuana is legal but recreational use remains broadly forbidden.

Read more »